Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
2.
Vet Pathol ; 53(2): 468-76, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26604215

ABSTRACT

Genetic and environmental factors both play a role in the occurrence of age-related disease. To examine the genetic contribution to the development of spontaneous lesions in aging animals, a complete range of tissues was comprehensively analyzed by histopathology from 180 individually housed ad libitum-fed or 40% calorically restricted 24-month-old male and female mice of 2 parental strains-DBA/2NNia (D2) and C57BL/6NNia (B6)-and the F1 cross B6D2F1/NNia. Several strain- and diet-dependent patterns of lesions were identified. Many lesions were genotype dependent and exhibited recessive phenotypic expression, defined as being common in 1 parental strain but infrequently observed in the F1 cross (eg, glomerulonephritis in B6 mice), while others were maintained from 1 parental strain to the F1 with similar frequencies (eg, reproductive tract leiomyoma in D2 mice). Other lesions were common regardless of genotype (osteoarthritis, periodontitis). Only rare lesions were more common in the F1 but underrepresented in the 2 parental strains. Furthermore, F1 mice had a lower number of overall total lesions and a lower number of tumors than either parental strain. Caloric restriction reduced the total number of lesions and neoplasms regardless of genotype but differentially affected genotype-dependent lesions in B6 and D2 mice, with B6 mice more sensitive to the effects of caloric restriction than D2 mice. In summary, genetics and environmental factors (eg, dietary restriction) both substantially contribute to the pattern of lesions that develop as animals age.


Subject(s)
Aging/pathology , Caloric Restriction , Gene-Environment Interaction , Neoplasms/genetics , Animals , Diet , Disease Models, Animal , Female , Genotype , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Neoplasms/pathology , Phenotype , Species Specificity
3.
Vet Pathol ; 52(4): 732-40, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25367367

ABSTRACT

In rhesus macaques, adenocarcinomas of either the ileocecal junction or colon are common spontaneous tumors in aging populations. The macaque tumors have similar gross and histologic characteristics compared with their human counterpart, but little is known regarding the immunohistochemical expression of proteins that are commonly implicated in the pathogenesis of these tumors in humans. We performed a retrospective review of 22 cases of large intestinal carcinoma in the rhesus macaque and evaluated the expression pattern of a panel of potentially prognostically significant proteins identified from human studies. Histologic characteristics of the tumors included abundant mucin deposition, transmural spread, and lymphatic invasion. All rhesus adenocarcinomas displayed altered expression of 1 or more of CD10, ß-catenin, sirtuin 1, cytokeratin 17, and p53 compared with age-matched controls. Zymographic analysis of active matrix metalloproteinases 2 and 9 in the serum from 5 animals failed to reveal statistically significant differences between adenocarcinoma cases and controls. Based on the data presented herein, large intestinal carcinomas in the macaque share many histomorphologic and immunohistochemical similarities to large intestinal tumors in humans. Further validation of this animal model is considered important for the development of novel therapeutics and a better understanding of the pathogenesis.


Subject(s)
Adenocarcinoma, Mucinous/veterinary , Biomarkers, Tumor/metabolism , Intestinal Neoplasms/veterinary , Monkey Diseases/pathology , Adenocarcinoma, Mucinous/pathology , Animals , Female , Immunohistochemistry/veterinary , Intestinal Mucosa/metabolism , Intestinal Neoplasms/pathology , Intestines/pathology , Macaca mulatta , Male , Mucins/metabolism , Prognosis , Retrospective Studies , beta Catenin/metabolism
4.
Gene Ther ; 21(9): 802-10, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24965083

ABSTRACT

Topical microbicides are a leading strategy for prevention of HIV mucosal infection to women; however, numerous pharmacokinetic limitations associated with coitally related dosing strategy have contributed to their limited success. Here we test the hypothesis that adeno-associated virus (AAV) mediated delivery of the b12 human anti-HIV-1 gp120 minibody gene to the lower genital tract of female rhesus macaques (Rh) can provide prolonged expression of b12 minibodies in the cervical-vaginal secretions. Gene transfer studies demonstrated that, of various green fluorescent protein (GFP)-expressing AAV serotypes, AAV-6 most efficiently transduced freshly immortalized and primary genital epithelial cells (PGECs) of female Rh in vitro. In addition, AAV-6-b12 minibody transduction of Rh PGECs led to inhibition of SHIV162p4 transmigration and virus infectivity in vitro. AAV-6-GFP could also successfully transduce vaginal epithelial cells of Rh when applied intravaginally, including p63+ epithelial stem cells. Moreover, intravaginal application of AAV-6-b12 to female Rh resulted in prolonged minibody detection in their vaginal secretions throughout the 79-day study period. These data provide proof of principle that AAV-6-mediated delivery of anti-HIV broadly neutralizing antibody (BnAb) genes to the lower genital tract of female Rh results in persistent minibody detection for several months. This strategy offers promise that an anti-HIV-1 genetic microbicide strategy may be possible in which topical application of AAV vector, with periodic reapplication as needed, may provide sustained local BnAb expression and protection.


Subject(s)
Epithelial Cells/virology , Genitalia, Female/metabolism , HIV Antibodies/metabolism , HIV Envelope Protein gp120/immunology , HIV Infections/prevention & control , HIV-1/metabolism , Macaca mulatta/virology , Animals , Cell Line , Dependovirus/genetics , Epithelial Cells/metabolism , Female , Genetic Vectors/administration & dosage , Genitalia, Female/cytology , Genitalia, Female/virology , HIV Antibodies/genetics , HIV Infections/immunology , HIV-1/immunology , HeLa Cells , Humans , Macaca mulatta/metabolism
5.
Br J Cancer ; 110(3): 648-55, 2014 Feb 04.
Article in English | MEDLINE | ID: mdl-24335920

ABSTRACT

BACKGROUND: Anti-EGFR antibody, cetuximab, improves overall survival (OS) in K-ras wild-type chemotherapy-refractory colorectal cancer. Epidermal growth factor receptor ligand epiregulin (EREG) gene expression may further predict cetuximab benefit. METHODS: Tumour samples from a phase III clinical trial of cetuximab plus best supportive care (BSC) vs BSC alone (CO.17) were analysed for EREG mRNA gene expression. Predictive effects of high vs low EREG on OS and progression-free survival (PFS) were examined for treatment-biomarker interaction. RESULTS: Both EREG and K-ras status were ascertained in 385 (193 cetuximab, 192 BSC) tumour samples. Within the high EREG and K-ras wild-type status ('co-biomarker')-positive group (n=139, 36%), median PFS was 5.4 vs 1.9 months (hazard ratio (HR) 0.31; P<0.0001), and median OS was 9.8 vs 5.1 months (HR 0.43; P<0.001) for cetuximab vs BSC, respectively. In the rest (n=246, 64%), PFS (HR 0.82; P=0.12) and OS (HR 0.90; P=0.45) were not significantly different. Test for treatment interaction showed a larger cetuximab effect on OS (HR 0.52; P=0.007) and PFS (HR 0.49; P=0.001) in the co-biomarker-positive group. CONCLUSION: In pre-treated K-ras wild-type status colorectal cancer, patients with high EREG gene expression appear to benefit more from cetuximab therapy compared with low expression. Epiregulin as a selective biomarker requires further evaluation.


Subject(s)
Antibodies, Monoclonal, Humanized/administration & dosage , Colorectal Neoplasms/drug therapy , Epidermal Growth Factor/biosynthesis , ras Proteins/genetics , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/genetics , Cetuximab , Clinical Trials, Phase III as Topic , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Disease-Free Survival , Epidermal Growth Factor/genetics , Epiregulin , Female , Gene Expression Regulation, Neoplastic , Humans , Male , Middle Aged , Mutation , Neoplasm Staging
6.
Vet Pathol ; 50(6): 1145-53, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23839235

ABSTRACT

A workshop on Emerging Respiratory Viral Infections and Spontaneous Diseases in nonhuman primates was sponsored by the concurrent Annual Meetings of the American College of Veterinary Pathologists and the American Society for Veterinary Clinical Pathology, held December 1-5, 2012, in Seattle, Washington. The session had platform presentations from Drs Karen Terio, Thijs Kuiken, Guy Boivin, and Robert Palermo that focused on naturally occurring influenza, human respiratory syncytial virus, and metapneumovirus in wild and zoo-housed great apes; the molecular biology and pathology of these viral respiratory diseases in nonhuman primate (NHP) models; and the therapeutic and vaccine approaches to prevention and control of these emerging respiratory viral infections. These formal presentations were followed by presentations of 14 unique case studies of rare or newly observed spontaneous lesions in NHPs (see online files for access to digital whole-slide images corresponding to each case report at http://scanscope.com/ACVP%20Slide%20Seminars/2012/Primate%20Pathology/view.apml). The session was attended by meeting participants that included students, pathology trainees, and experienced pathologists from academia and industry with an interest in respiratory and spontaneous diseases of NHPs.


Subject(s)
Macaca , Pan troglodytes , Papio , Primate Diseases/virology , Respiratory Tract Infections/veterinary , Virus Diseases/veterinary , Animals , Female , Macaca fascicularis , Macaca mulatta , Macaca nemestrina , Male , Respiratory Tract Infections/virology , Virus Diseases/virology
7.
Vet Pathol ; 49(6): 1057-69, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23135296

ABSTRACT

The combination of loss of habitat, human population encroachment, and increased demand of select nonhuman primates for biomedical research has significantly affected populations. There remains a need for knowledge and expertise in understanding background findings as related to the age, source, strain, and disease status of nonhuman primates. In particular, for safety/biomedical studies, a broader understanding and documentation of lesions would help clarify background from drug-related findings. A workshop and a minisymposium on spontaneous lesions and diseases in nonhuman primates were sponsored by the concurrent Annual Meetings of the American College of Veterinary Pathologists and the American Society for Veterinary Clinical Pathology held December 3-4, 2011, in Nashville, Tennessee. The first session had presentations from Drs Lowenstine and Montali, pathologists with extensive experience in wild and zoo populations of nonhuman primates, which was followed by presentations of 20 unique case reports of rare or newly observed spontaneous lesions in nonhuman primates (see online files for access to digital whole-slide images corresponding to each case report at http://www.scanscope.com/ACVP%20Slide%20Seminars/2011/Primate%20Pathology/view.apml). The minisymposium was composed of 5 nonhuman-primate researchers (Drs Bradley, Cline, Sasseville, Miller, Hutto) who concentrated on background and spontaneous lesions in nonhuman primates used in drug safety studies. Cynomolgus and rhesus macaques were emphasized, with some material presented on common marmosets. Congenital, acquired, inflammatory, and neoplastic changes were highlighed with a focus on clinical, macroscopic, and histopathologic findings that could confound the interpretation of drug safety studies.


Subject(s)
Animals, Wild , Animals, Zoo , Primate Diseases/pathology , Primates , Animal Experimentation , Animals , Biomedical Research , Drug Evaluation, Preclinical , Female , Macaca fascicularis , Macaca mulatta , Male , Models, Animal
8.
Br J Cancer ; 104(3): 488-95, 2011 Feb 01.
Article in English | MEDLINE | ID: mdl-21206494

ABSTRACT

BACKGROUND: Although it is accepted that metastatic colorectal cancers (mCRCs) that carry activating mutations in KRAS are unresponsive to anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, a significant fraction of KRAS wild-type (wt) mCRCs are also unresponsive to anti-EGFR therapy. Genes encoding EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are promising gene expression-based markers but have not been incorporated into a test to dichotomise KRAS wt mCRC patients with respect to sensitivity to anti-EGFR treatment. METHODS: We used RT-PCR to test 110 candidate gene expression markers in primary tumours from 144 KRAS wt mCRC patients who received monotherapy with the anti-EGFR antibody cetuximab. Results were correlated with multiple clinical endpoints: disease control, objective response, and progression-free survival (PFS). RESULTS: Expression of many of the tested candidate genes, including EREG and AREG, strongly associate with all clinical endpoints. Using multivariate analysis with two-layer five-fold cross-validation, we constructed a four-gene predictive classifier. Strikingly, patients below the classifier cutpoint had PFS and disease control rates similar to those of patients with KRAS mutant mCRC. CONCLUSION: Gene expression appears to identify KRAS wt mCRC patients who receive little benefit from cetuximab. It will be important to test this model in an independent validation study.


Subject(s)
Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/genetics , Proto-Oncogene Proteins/genetics , ras Proteins/genetics , Antibodies, Monoclonal/therapeutic use , Antibodies, Monoclonal, Humanized , Antineoplastic Agents/therapeutic use , Cetuximab , Colorectal Neoplasms/secondary , Drug Resistance, Neoplasm/genetics , Gene Expression , Humans , Proto-Oncogene Proteins p21(ras)
9.
Cell ; 106(6): 697-708, 2001 Sep 21.
Article in English | MEDLINE | ID: mdl-11572776

ABSTRACT

Genome-wide location analysis was used to determine how the yeast cell cycle gene expression program is regulated by each of the nine known cell cycle transcriptional activators. We found that cell cycle transcriptional activators that function during one stage of the cell cycle regulate transcriptional activators that function during the next stage. This serial regulation of transcriptional activators forms a connected regulatory network that is itself a cycle. Our results also reveal how the nine transcriptional regulators coordinately regulate global gene expression and diverse stage-specific functions to produce a continuous cycle of cellular events. This information forms the foundation for a complete map of the transcriptional regulatory network that controls the cell cycle.


Subject(s)
Cell Cycle/genetics , Gene Expression Regulation, Fungal , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/genetics , Trans-Activators/metabolism , Transcription Factors/metabolism , Cyclin-Dependent Kinases/genetics , Cyclins/genetics , Genome, Fungal
10.
Mol Biol Cell ; 12(2): 323-37, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11179418

ABSTRACT

We used genome-wide expression analysis to explore how gene expression in Saccharomyces cerevisiae is remodeled in response to various changes in extracellular environment, including changes in temperature, oxidation, nutrients, pH, and osmolarity. The results demonstrate that more than half of the genome is involved in various responses to environmental change and identify the global set of genes induced and repressed by each condition. These data implicate a substantial number of previously uncharacterized genes in these responses and reveal a signature common to environmental responses that involves approximately 10% of yeast genes. The results of expression analysis with MSN2/MSN4 mutants support the model that the Msn2/Msn4 activators induce the common response to environmental change. These results provide a global description of the transcriptional response to environmental change and extend our understanding of the role of activators in effecting this response.


Subject(s)
Adaptation, Physiological/genetics , Gene Expression Regulation, Fungal , Saccharomyces cerevisiae Proteins , Yeasts/physiology , DNA-Binding Proteins/genetics , Enzymes/genetics , Gene Expression Profiling , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Fungal/drug effects , Genome, Fungal , Heat-Shock Response/genetics , Hydrogen Peroxide/pharmacology , Hydrogen-Ion Concentration , Mutation , Osmotic Pressure , Salts/pharmacology , Transcription Factors/genetics , Yeasts/drug effects
11.
Support Care Cancer ; 8(2): 102-9, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10739356

ABSTRACT

Despite increasing interest in the relationship between religious involvement and health outcomes for cancer patients, research has been limited by the lack of appropriate measures. Few of the many instruments available are well suited to cancer patients. The current study examined the psychometric properties of one recently developed measure, the Duke Religious Index (DRI), which assesses several aspects of religious involvement. The DRI was evaluated in two distinct samples: 104 cancer patients receiving treatment at a bone marrow transplantation program and 175 gynecology clinic patients. The instrument demonstrated good internal consistency (coefficient alphas 0.87-0.94). Moderate to high correlations with other measures of religiosity provided support for convergent validity. Modest relationships with other measures commonly used in psychosocial oncology (e.g., optimism, social support, purpose in life) indicated that the instrument provides unique information (all rs's < 0. 42). Small relationships with social desirability response bias, negative affect, and relationship cohesion further supported the divergent validity of the instrument (all rs's < 0.22). The DRI was significantly associated with demographic characteristics but not with medical variables. Findings support the value of the DRI for use in oncology settings.


Subject(s)
Neoplasms/psychology , Outcome Assessment, Health Care , Religion and Medicine , Surveys and Questionnaires/standards , Terminal Care , Adult , Arkansas , Female , Humans , Male , Middle Aged , Reproducibility of Results
12.
Appl Environ Microbiol ; 65(9): 4271-5, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10473452

ABSTRACT

The diversity of a microbial community covering the surface of a marine nematode was analyzed by performing a 16S ribosomal DNA (rDNA) restriction cutting and sequencing analysis. In two clone libraries constructed by using individual nematodes, 54 and 85 restriction patterns were identified, and only 13 of these patterns were common to both libraries. Sequence analysis indicated that the common patterns belonged to four groups related to sequences of cytophagas, sulfate-reducing bacteria, members of the gamma subclass of the class Proteobacteria, and caulobacters. At least two groups appeared to be permanent members of the community as they were also detected in a 16S rDNA library constructed 3 years previously by using 100 pooled nematode specimens. A surprising outcome was that very dominant filamentous bacteria were apparently not represented in the clone libraries, as quantitative probing showed that none of the common operational taxonomic unit groups displayed the expected overwhelming dominance. Nevertheless, our analysis revealed both an unexpectedly high level of bacterial diversity and heterogeneity in samples representing presumably very similar microenvironments.


Subject(s)
Bacteria/classification , Bacteria/genetics , Nematoda/microbiology , Animals , DNA, Bacterial/genetics , DNA, Ribosomal/genetics , Ecosystem , Genetic Variation , Marine Biology , Molecular Sequence Data , Phylogeny , RNA, Ribosomal, 16S/genetics , Restriction Mapping , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...